Abiopharma

Sarepta Therapeutics Acknowledges CHMP Negative Opinion for ELEVIDYS in the European Union

New Form 25-NSE - Verve Therapeutics, Inc. Filed: 2025-07-25 AccNo: 0001354457-25-000739 Size: 2 KB

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

Schrödinger, Inc. - Schrödinger to Announce Second Quarter 2025 Financial Results on August 6

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

New Form DEFA14A - ZimVie Inc. Filed: 2025-07-25 AccNo: 0001193125-25-164864 Size: 32 KB

New Form 6-K - GSK plc Filed: 2025-07-25 AccNo: 0001654954-25-008470 Size: 3 MB

New Form 8-K - OMEROS CORP Filed: 2025-07-25 AccNo: 0001104659-25-070554 Size: 564 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 424B5 - OMEROS CORP Filed: 2025-07-25 AccNo: 0001104659-25-070553 Size: 605 KB

New Form 8-K - CareCloud, Inc. Filed: 2025-07-25 AccNo: 0001493152-25-011403 Size: 291 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Lyell Immunopharma, Inc. Filed: 2025-07-25 AccNo: 0001193125-25-164853 Size: 523 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025

Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025

ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025

Lyell Immunopharma Announces up to $100 Million Equity Private Placement